Nifty 17401.65 (1.37%)
Sensex 58461.29 (1.35%)
Nifty Bank 36508.25 (0.39%)
Nifty IT 36157.85 (2.06%)
Nifty Financial Services 17982.9 (1.26%)
Adani Ports 739.10 (4.40%)
Asian Paints 3180.60 (1.35%)
Axis Bank 676.10 (-0.52%)
B P C L 378.85 (2.74%)
Bajaj Auto 3328.40 (2.43%)
Bajaj Finance 7180.50 (2.01%)
Bajaj Finserv 17758.15 (2.16%)
Bharti Airtel 732.55 (1.43%)
Britannia Inds. 3578.50 (1.22%)
Cipla 921.25 (-0.74%)
Coal India 159.30 (2.41%)
Divis Lab. 4777.30 (0.53%)
Dr Reddys Labs 4662.75 (1.22%)
Eicher Motors 2451.55 (0.54%)
Grasim Inds 1723.85 (2.63%)
H D F C 2807.80 (3.85%)
HCL Technologies 1184.70 (2.42%)
HDFC Bank 1525.75 (1.40%)
HDFC Life Insur. 705.30 (1.65%)
Hero Motocorp 2472.70 (1.00%)
Hind. Unilever 2383.30 (1.64%)
Hindalco Inds. 432.10 (1.69%)
I O C L 120.65 (2.51%)
ICICI Bank 722.40 (-0.73%)
IndusInd Bank 945.55 (1.27%)
Infosys 1748.25 (1.94%)
ITC 225.45 (1.60%)
JSW Steel 646.75 (1.50%)
Kotak Mah. Bank 1964.25 (0.56%)
Larsen & Toubro 1789.20 (0.18%)
M & M 849.55 (1.78%)
Maruti Suzuki 7324.95 (0.71%)
Nestle India 19503.20 (0.54%)
NTPC 128.70 (0.78%)
O N G C 144.00 (1.23%)
Power Grid Corpn 214.50 (3.52%)
Reliance Industr 2482.85 (0.64%)
SBI Life Insuran 1188.05 (1.99%)
Shree Cement 26289.80 (0.76%)
St Bk of India 477.00 (0.36%)
Sun Pharma.Inds. 766.25 (2.80%)
Tata Consumer 773.25 (0.06%)
Tata Motors 479.10 (0.81%)
Tata Steel 1112.40 (2.76%)
TCS 3642.90 (1.82%)
Tech Mahindra 1629.65 (2.65%)
Titan Company 2386.50 (1.11%)
UltraTech Cem. 7323.20 (0.01%)
UPL 698.20 (1.12%)
Wipro 646.80 (1.89%)
INFY

Torrent Pharmaceuticals L..

₹2971.15
Not a customer?

Open free demat account
& trade instantly

Investment Ratings

As per analysts rating in the last 6 months, the recommendation is to HOLD Torrent Pharma.

  • Master Rating:
  • Torrent Pharmaceuticals has an operating revenue of Rs. 8,203.00 Cr. on a trailing 12-month basis. An annual revenue de-growth of 0% needs improvement, Pre-tax margin of 19% is great, ROE of 21% is exceptional. The company has a reasonable debt to equity of 50%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 5% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 8% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 43 which is a POOR score indicating inconsistency in earnings, a RS Rating of 28 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 149 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Torrent Pharmaceuticals Ltd Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Ratings

Eps And Sales Estimates

Torrent Pharmaceuticals Ltd Synopsis

NSE-Medical-Generic Drugs

Torrent Pharmac is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 6450.83 Cr. and Equity Capital is Rs. 84.62 Cr. for the Year ended 31/03/2021. Torrent Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 15/07/1972 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1972PLC002126 and registration number is 002126.
  • Market Cap

    INR 50,278.69 Cr

  • Sales

    INR 6,578.00 Cr

  • Shares in Float

    4.91 Cr

  • No of Funds

    491 K

  • Yield

    1.18%

  • Book Value

    8.34

  • U/D Vol Ratio

    1

  • LTDebt/Equity

    49%

  • Alpha

    -0.01

  • Beta

    0.53

Torrent Pharmaceuticals Ltd Ownership
Torrent Pharmaceuticals Ltd Management

Torrent Pharmaceuticals Ltd Financials

INDICATORMar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Total ShareHolders Funds Annual Cr 6030.15120.975015.274556.494453.71
Fixed Assets Annual Cr 7329.357733.917922.737875.913996.56
Total Non Current Assets Annual Cr 7619.168065.218278.328180.934505.33
Total Current Assets Annual Cr 4141.883819.263748.953639.053545.49
Total Assets Annual Cr 11761.0411884.4712027.2711820.078050.91
INDICATORMar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Book Value Per Share Annual Rs 356.3045302.586296.3405269.232263.159
ROE Annual % 18.8618.3214.8610.5719.17
ROCE Annual % 18.5818.215.849.6816.78
Total Debt to Total Equity Annual -----
EBDIT Annual Margin % 35.8934.9134.6229.1831.06

Torrent Pharmaceuticals Ltd Technicals

EMA & SMA

CURRENT PRICE

2971.15 (-0.15)

    • Bullish Moving Averages 12
    • Bearish Moving Averages 4

EMA

  • 20 Day

    2921.16

  • 50 Day

    2947.73

  • 100 Day

    2936.26

  • 200 Day

    2829.8

Torrent Pharmaceuticals Ltd Resistance and support

2987.15 PIVOT

  • First Resistance

    3023.5

  • Second Resistance

    3071.35

  • Third Resistance

    3107.7

  • First Support

    2939.3

  • Second Support

    2902.95

  • Third Support

    2855.1

  • RSI

    54.43

  • MFI

    59.39

  • MACD

    13.4

  • MACD signal line

    -14.84

Torrent Pharmaceuticals Ltd Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 246,472 15,214,717 61.73%
Week 579,766 18,523,517 31.95%
1 Month 382,909 14,964,093 39.08%
6 Month 223,564 8,446,246 37.78%

Torrent Pharmaceuticals Ltd Price change analysis

132.1

Over 1 month

Low High
2734.5 3248.8

-172

Over 3 month

Low High
2734.5 3250.2

176.15

Over 6 months

Low High
2734.5 3250.2

281.1

Over Year

Low High
2311.1 3250.2

Similar Stocks

News

Torrent Pharma's positive India show infuses confidence

The weak link remains US sales as regulatory issues with the USFDA on its two manufacturing facilities stand Read More

Torrent Pharmaceuticals Ltd - 500420 - Announcement under Re

Intimation of Schedule of Investor Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Read More

Torrent Pharmaceuticals Ltd - 500420 - Compliances-Reg. 39 (

Intimation of Loss of Share Certificate Read More

Torrent Pharmaceuticals Ltd - 500420 - Announcement under Re

Intimation of Schedule of Investor Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Read More

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under R

Intimation of rescheduling of Investor/Analyst Meet In furtherance to our letter dated 27-Oct-21 on the captioned subject, we would like to Read More

Blogs

FAQs